ECP 2023 Final Programme

Poster Sessions a Wednesday 105 ECP 2023 Dublin Wednesday, 13Sept PS-24 PS-23 006 Loss of F-Box and leucine rich repeat protein 5 (FBXL5) expression is associated with poor survival in patients with hepatocellular carcinoma Yoon Ah Cho, Korea S. Kim, C. Park, S. Ha 007 Molecular heterogeneity of Primary liver carcinomas: early study Joana Espírito Santo, Portugal A. Ladeirinha, A. Alarcão, E. Strelet, M. Reis, R. Santos, L. Carvalho 008 An HE-only workflow for liver fibrosis assessment using HE-predicted collagen Rutger Fick, France G. Balezo, C. Bertram, C. Tilmant, S. Petit, S. Ben Hadj 009 Hepatic resection for colorectal cancer metastases: the role of the histopathologist as a bridge between science and medicine when assessing background liver pathology following chemotherapy Matthew Hanks, United Kingdom L. Khasati, C. Santos, A. Zaitoun 010 Digital spital profiling reveals possible predictive and prognostic markers in pancreatic cancer Se In Jeong, Korea K. Lee, S. Lee, J. Lee, H. Na, J. Kim 011 Multi-regional analysis of combined hepatocellular-cholangiocarcinoma reveals histologic diversity and molecular clonality Young Eun Kim, Korea H. Na, H. Kim, J. Kim, S. Ahn 013 An immunohistochemical study of MAGE proteins in hepatocellular carcinoma Maria Lambropoulou, Greece S. Tologkos, V. Papadatou, A. Panagiotopoulos, T. Alexiadis, A. Mitrakas, C. Alexiadi, V. Lampropoulou, C. Nikolaidou, G. Tripsianis 014 GAD2 is a highly specific marker for neuroendocrine neoplasms of the pancreas Maximilian Lennartz, Germany N. Dünnebier, N. Blessin, D. Hoeflmayer, S. Dwertmann Rico, S. Kind, C. Fraune, N. Gorbokon, C. Hube-Magg, F. Büscheck, A. Menz, G. Sauter, R. Simon, S. Minner, C. Bernreuther 015 RNF135 promoter methylation as a potential diagnostic biomarker distinguish- ing hepatocellular carcinoma from other adenocarcinomas Branislava Rankovic, Slovenia T. Draškovič, N. Zidar, N. Hauptman 016 TIMP1 as venous invasion marker in pancreatic ductal adenocarcinoma You-Na Sung, Korea M. Kim, S. Hong PS-24 Poster Session 09:30–10:30 Foyer 3rd Floor Poster Session Molecular Pathology Chair: Esther Conde Gallego, Spain 001 A real-world experience from a single centre (LPCE, Nice, France) highlights the urgent need to abandon immunohistochem- istry for ROS1 rearrangement screening of advanced non-squamous non-small cell lung cancer Christophe Bontoux, France V. Hofman, S. Goffinet, E. Long-Mira, S. Lassalle, M. Ilié, P. Hofman 002 Pulmonary Adenocarcinoma: ALK, ROS1 and RET imbalance sequencing concomi- tant with other target mutations Lina Carvalho, Portugal M. Silva, A. Alarcão, A. Ladeirinha, T. Ferreira, C. Eliseu, M. Viseu, V. Almeida, G. Fontinha, V. Sousa